Benefit with cardiac myosin activator in HFrEF
This video was recorded during the virtual congress of the AHA Scientific Sessions 2020.
Dr. John R. Teerlink is Director of Heart Failure and of the Echocardiography Laboratory at the San Francisco Veterans Affairs Medical Center in San Francisco, California and Professor of Clinical Medicine at UCSF.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: